All Stories

  1. Towards evidence-based medicine for paediatricians
  2. Accuracy and Reliability of Remote Shoulder Motion Capturing Methods: A Systematic Review and Meta-Analysis
  3. A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children
  4. Priority setting for supportive care research in children and young people with cancer
  5. Towards evidence-based medicine for paediatricians
  6. Towards evidence-based medicine for paediatricians
  7. Do Surveillance Tests for Relapse Improve Survival After Chemotherapy for Paediatric Acute Leukaemia? A Systematic Review
  8. ‘All I Had to Do Was Open My Mouth Wide’—A Qualitative Exploration of the Acceptability of Photobiomodulation for Oral Mucositis Management in Paediatric Supportive Care
  9. Towards evidence-based medicine for paediatricians
  10. The Dangerousness of a Devilled Egg
  11. “That's All Anyone Needs Really, Support”: A Content Analysis of Retinoblastoma Survivors’ Psychosocial Support Needs
  12. Towards evidence-based medicine for paediatricians
  13. Towards evidence-based medicine for paediatricians
  14. Towards evidence-based medicine for paediatricians
  15. End of life care in paediatric settings: UK national survey
  16. Towards evidence-based medicine for paediatricians
  17. Towards evidence-based medicine for paediatricians
  18. Towards evidence-based medicine for paediatricians
  19. Towards evidence-based medicine for paediatricians
  20. Towards evidence-based medicine for paediatricians
  21. Towards evidence-based medicine for paediatricians
  22. Negotiating Neutrality: Designing a Responsive Video to Support Fertility Preservation Decision-making by Cancer-diagnosed Young Female Patients
  23. Towards evidence-based medicine for paediatricians
  24. Towards evidence-based medicine for paediatricians
  25. Consent and assent in paediatric practice: it’s the conversation that matters
  26. A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local‐REFoRMS)
  27. ‘It’s not meant to be for life, but it carries on’: a qualitative investigation into the psychosocial needs of young retinoblastoma survivors
  28. Towards evidence-based medicine for paediatricians
  29. Towards evidence-based medicine for paediatricians
  30. Towards evidence-based medicine for paediatricians
  31. Towards evidence-based medicine for paediatricians
  32. Lumps or granules?
  33. Towards evidence-based medicine for paediatricians
  34. Towards evidence-based medicine for paediatricians
  35. An analysis of the resource use and costs of febrile neutropenia events in pediatric cancer patients in Australia
  36. Towards evidence-based medicine for paediatricians
  37. Consultant-led UK paediatric palliative care services: professional configuration, services, funding
  38. Methods for including adult evidence in children's research.
  39. Towards evidence-based medicine for paediatricians
  40. Towards evidence-based medicine for paediatricians
  41. Comparison of Bayesian methods for incorporating adult clinical trial data to improve certainty of treatment effect estimates in children
  42. Towards evidence-based medicine for paediatricians
  43. Towards evidence-based medicine for paediatricians
  44. Using Evidence-Based Medicine to Support Clinical Decision-Making in RMS
  45. Can I go home now? The safety and efficacy of a new UK paediatric febrile neutropenia protocol for risk-stratified early discharge on oral antibiotics
  46. Towards evidence-based medicine for paediatricians
  47. An exploration of the use of photobiomodulation for management of oral mucositis in children and young people undergoing cancer treatment in the UK
  48. Towards evidence-based medicine for paediatricians
  49. Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients
  50. Towards evidence-based medicine for paediatricians
  51. Towards evidence-based medicine for paediatricians
  52. End of life care for infants, children and young people (ENHANCE): Protocol for a mixed methods evaluation of current practice in the United Kingdom
  53. Towards evidence-based medicine for paediatricians
  54. Towards evidence-based medicine for paediatricians
  55. PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study
  56. Towards evidence-based medicine for paediatricians
  57. Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with fever and neutropenia
  58. Towards evidence-based medicine for paediatricians
  59. Towards evidence-based medicine for paediatricians
  60. SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients
  61. Towards evidence-based medicine for paediatricians
  62. Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with fever and neutropenia
  63. Towards evidence-based medicine for paediatricians
  64. Towards evidence-based medicine for paediatricians
  65. Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update
  66. Towards evidence-based medicine for paediatricians
  67. COVID-19 in children with haematological malignancies
  68. Towards evidence-based medicine for paediatricians
  69. Reporting the whole story: Analysis of the ‘out‐of‐scope’ questions from the James Lind Alliance Teenage and Young Adult Cancer Priority Setting Partnership Survey
  70. Low-level laser therapy for oral mucositis in children with cancer
  71. External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb
  72. Mucositis reduction with probiotics in children with cancer: a randomised-controlled feasibility study
  73. Towards evidence-based medicine for paediatricians
  74. Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia
  75. Towards evidence-based medicine for paediatricians
  76. Towards evidence-based medicine for paediatricians
  77. Towards evidence-based medicine for paediatricians
  78. Olanzapine was an effective additional antiemetic for children and young people undergoing highly emetogenic chemotherapy
  79. Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update
  80. UK paediatric oncology Pneumocystis jirovecii pneumonia surveillance study
  81. Towards evidence-based medicine for paediatricians
  82. Can low-dose dexamethasone be used instead of prednisolone in acute asthma attacks?
  83. Towards evidence-based medicine for paediatricians
  84. Towards evidence-based medicine for paediatricians
  85. Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project
  86. Improving symptom control and reducing toxicities for pediatric patients with hematological malignancies
  87. COVID‐19 and children with cancer: Parents’ experiences, anxieties and support needs
  88. Towards evidence-based medicine for paediatricians
  89. Towards evidence-based medicine for paediatricians
  90. Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
  91. Towards evidence-based medicine for paediatricians
  92. Conventional compared to network meta-analysis to evaluate antibiotic prophylaxis in patients with cancer and haematopoietic stem cell transplantation recipients
  93. Towards evidence-based medicine for paediatricians
  94. Home-based care of low-risk febrile neutropenia in children—an implementation study in a tertiary paediatric hospital
  95. Meta‐analytic validation of new ‘AUS’ febrile neutropenia risk score
  96. Towards evidence-based medicine for paediatricians
  97. Towards evidence-based medicine for paediatricians
  98. COVID-19 and children with cancer: Parents' experiences, anxieties, and support needs
  99. Prevalence of anticipatory nausea and vomiting in children undergoing cytotoxic chemotherapy for malignant disease - the SiCK2 (Sickness prior to Chemotherapy in Kids) study
  100. Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia
  101. Children and young people’s concerns and needs relating to their use of health technology to self-manage long-term conditions: a scoping review
  102. A systematic review of evidence for and against routine surveillance imaging after completing treatment for childhood extracranial solid tumors
  103. Towards evidence-based medicine for paediatricians
  104. Sharing Roles and Control in Pediatric Low Risk Febrile Neutropenia: A Multicenter Focus Group Discussion Study Involving Patients, Parents, and Health Care Professionals
  105. Specialist paediatric palliative care for children and young people with cancer: A mixed-methods systematic review
  106. Towards evidence-based medicine for paediatricians
  107. Diagnostic Yield of Initial and Consecutive Blood Cultures in Children With Cancer and Febrile Neutropenia
  108. Towards evidence-based medicine for paediatricians
  109. Short-course antibiotics for chemotherapy-induced febrile neutropaenia: retrospective cohort study
  110. Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients
  111. Towards evidence-based medicine for paediatricians
  112. Sensitivity of the Kaiser Permanente early-onset sepsis calculator: A systematic review and meta-analysis
  113. Lexicon for guidance terminology in pediatric hematology/oncology: A White Paper
  114. What’s not being said?
  115. Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules
  116. Towards evidence-based medicine for paediatricians
  117. Towards evidence-based medicine for paediatricians
  118. New developments in the prevention and management of infections in children with cancer
  119. Individual participant data validation of the PICNICC prediction model for febrile neutropenia
  120. Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
  121. Long duration of antibiotic therapy
  122. Towards evidence-based medicine for paediatricians
  123. Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant
  124. Neonates are not little children
  125. Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review
  126. Recommended technology to relieve oral mucositis not yet available for children or young people in England or Wales
  127. Towards evidence-based medicine for paediatricians
  128. Research priorities for young people with cancer: a UK priority setting partnership with the James Lind Alliance
  129. Towards evidence-based medicine for paediatricians
  130. Does routine surveillance imaging after completing treatment for childhood solid tumours cause more harm than good? A systematic review and meta-analysis protocol
  131. Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review
  132. How to navigate the ethical review of research
  133. Towards evidence-based medicine for paediatricians
  134. Framework to help design and review research involving children
  135. Towards evidence-based medicine for paediatricians
  136. How to involve children and young people in what is, after all, their research
  137. Towards evidence-based medicine for paediatricians
  138. Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA
  139. Making research central to good paediatric practice
  140. Towards evidence-based medicine for paediatricians
  141. Fifteen-minute consultation: A guide to managing a child with a new finding of neutropenia
  142. Towards evidence-based medicine for paediatricians
  143. What do families want to improve in the management of paediatric febrile neutropenia during anti-cancer treatment? Report of a patient/public involvement group
  144. Refreshing
  145. Treating extravasation injuries in infants and young children: a scoping review and survey of UK NHS practice
  146. Towards evidence-based medicine for paediatricians
  147. Melatonin in children with cancer
  148. Towards evidence-based medicine for paediatricians
  149. The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high‐grade central nervous system tumors: a systematic review
  150. Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients
  151. Towards evidence-based medicine for paediatricians
  152. Towards evidence-based medicine for paediatricians
  153. Towards evidence-based medicine for paediatricians
  154. Treatment of extravasation injuries in infants and young children: a scoping review and survey
  155. Towards evidence-based medicine for paediatricians
  156. What is experimental?
  157. The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review
  158. Quest for certainty regarding early discharge in paediatric low-risk febrile neutropenia: a multicentre qualitative focus group discussion study involving patients, parents and healthcare professionals in the UK
  159. Winter 2017 Children’s Cancer and Leukaemia Group febrile neutropenia audit
  160. Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer
  161. Towards evidence-based medicine for paediatricians
  162. External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules
  163. Towards evidence-based medicine for paediatricians
  164. ‘Inconguous’
  165. Je ne regrette rien?
  166. Towards evidence-based medicine for paediatricians
  167. Accuracy of cystatin C for the detection of abnormal renal function in children undergoing chemotherapy for malignancy: a systematic review using individual patient data
  168. Towards evidence based medicine for paediatricians
  169. “Let them eat strawberries”: Dietary restrictions for children with cancer
  170. Validation of a classification system for treatment-related mortality in children with cancer
  171. Bowing fracture of the inferior angle of the scapula, a difficult diagnosis
  172. Towards evidence-based medicine for paediatricians
  173. Towards evidence based medicine for paediatricians
  174. Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis
  175. Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study
  176. Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review
  177. Videolaryngoscopy versus direct laryngoscopy for tracheal intubation in children (excluding neonates)
  178. Towards evidence-based medicine for paediatricians
  179. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update
  180. Guidelines for the Prophylaxis of Pneumocystis jirovecii Pneumonia (PJP) in Children With Solid Tumors
  181. Towards evidence based medicine for paediatricians
  182. Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol
  183. Multi-Professional Perspectives on Adolescent and Young Adult Oncology Across Europe: An e-Delphi Survey
  184. Towards evidence based medicine for paediatricians
  185. Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
  186. Towards evidence based medicine for paediatricians
  187. Clinical presentation of childhood leukaemia: a systematic review and meta-analysis
  188. Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology
  189. Risk stratification in febrile neutropenic episodes in adolescent/young adult patients with cancer
  190. The impact of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis
  191. Galactomannan, β-D-Glucan, and Polymerase Chain Reaction–Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
  192. Towards evidence based medicine for paediatricians
  193. Systematic review and meta‐analysis of the risk of severe and life‐threatening thromboembolism in cancer patients receiving anti‐EGFR monoclonal antibodies (cetuximab or panitumumab)
  194. The effectiveness and safety of proton beam radiation therapy in children with malignant central nervous system (CNS) tumours: protocol for a systematic review
  195. Towards evidence based medicine for paediatricians
  196. Strategies facilitating practice change in pediatric cancer: a systematic review
  197. Towards evidence based medicine for paediatricians
  198. Towards evidence based medicine for paediatricians
  199. Faculty of 1000 evaluation for Validation of two algorithms for managing children with a non-blanching rash.
  200. Guideline on children with challenging chemotherapy-induced nausea and vomiting
  201. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis
  202. Letter to the editor
  203. Towards evidence based medicine for paediatricians
  204. Variation in practice remains in the UK management of paediatric febrile neutropenia
  205. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood
  206. Aminoaciduria in the prediction of ifosfamide-induced tubulopathy after childhood cancer: a feasibility study
  207. Towards evidence based medicine for paediatricians
  208. QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?: Table 1
  209. Systematic review of reduced therapy regimens for children with low risk febrile neutropenia
  210. Towards evidence based medicine for paediatricians
  211. Classification of treatment-related mortality in children with cancer: a systematic assessment
  212. Management of fever and neutropenia in paediatric cancer patients
  213. The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis
  214. Towards evidence based medicine for paediatricians
  215. Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials
  216. Towards evidence based medicine for paediatricians
  217. Faculty of 1000 evaluation for Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation.
  218. Towards evidence based medicine for paediatricians
  219. Nutritional support in children and young people with cancer undergoing chemotherapy
  220. Towards evidence based medicine for paediatricians
  221. Faculty of 1000 evaluation for Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis.
  222. Faculty of 1000 evaluation for Saline vs Tissue Plasminogen Activator Irrigations after Drain Placement for Appendicitis-Associated Abscess: A Prospective Randomized Trial.
  223. Towards evidence based medicine for paediatricians
  224. Faculty of 1000 evaluation for Large observer variation of clinical assessment of dyspnoeic wheezing children.
  225. Systematic Review and Meta-Analysis of Outcomes after Cardiopulmonary Arrest in Childhood
  226. Towards evidence based medicine for paediatricians
  227. Towards evidence based medicine for paediatricians
  228. Towards evidence based medicine for paediatricians
  229. Towards evidence based medicine for paediatricians
  230. PAWS for thought
  231. Faculty of 1000 evaluation for Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs.
  232. Bronchoalveolar Lavage and Lung Biopsy in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review and Meta-Analysis
  233. An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review
  234. Towards evidence based medicine for paediatricians
  235. Video-laryngoscopy versus direct laryngoscopy for tracheal intubation in children (excluding neonates)
  236. Critical Review of Clinical Practice Guidelines for Fertility Preservation in Teenagers and Young Adults with Cancer
  237. Core outcomes and definitions for pediatric fever and neutropenia research: A consensus statement from an international panel
  238. Towards evidence based medicine for paediatricians
  239. Question 2: Does the timing of central line placement in relationship to the initiation of acute lymphoblastic leukaemia therapy change the risk of thrombosis or infection?: Table 1
  240. Protocol for a systematic review of reductions in therapy for children with low-risk febrile neutropenia
  241. UK survey ofPneumocystis jiroveciiPneumonia (PJP) prophylaxis use in paediatric oncology patients: Table 1
  242. Mind the gap: extent of use of diffusion-weighted MRI in children with rhabdomyosarcoma
  243. Towards evidence based medicine for paediatricians
  244. A meta-analysis of cognitive impairment following adult cancer chemotherapy.
  245. Towards evidence based medicine for paediatricians
  246. Towards evidence based medicine for paediatricians
  247. Towards evidence based medicine for paediatricians
  248. Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients
  249. Towards evidence based medicine for paediatricians
  250. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis
  251. Faculty of 1000 evaluation for Hypotonic versus Isotonic Fluids in Hospitalized Children: A Systematic Review and Meta-Analysis.
  252. Towards evidence based medicine for paediatricians
  253. Faculty of 1000 evaluation for Topical Lidocaine to Improve Oral Intake in Children With Painful Infectious Mouth Ulcers: A Blinded, Randomized, Placebo-Controlled Trial.
  254. Towards evidence based medicine for paediatricians
  255. Increasing value and reducing waste in biomedical research regulation and management
  256. Towards evidence based medicine for paediatricians
  257. Towards evidence based medicine for paediatricians
  258. An Updated Systematic Review and Meta-analysis of the Predictive Value of Serum Biomarkers in the Assessment of Fever During Neutropenia in Children With Cancer
  259. Towards evidence based medicine for paediatricians
  260. Faculty of 1000 evaluation for Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schönlein purpura (HSP).
  261. Faculty of 1000 evaluation for Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study.
  262. Towards evidence based medicine for paediatricians
  263. The use of social-networking sites in medical education
  264. The reporting of outcomes in studies of fever and neutropenia in children with cancer: Time for consensus
  265. Towards evidence based medicine for paediatricians
  266. Question 2 * Can a conservative approach to the treatment of hypertrophic pyloric stenosis with atropine be considered a real alternative to surgical pyloromyotomy?
  267. Towards evidence based medicine for paediatricians
  268. A reaudit of current febrile neutropenia practice in UK paediatric oncology centres prior to implementation of NICE guidance
  269. Faculty of 1000 evaluation for Ultrasonographically guided peripheral intravenous cannulation of children and adults: A systematic review and meta-analysis.
  270. Faculty of 1000 evaluation for Cancer in children with nonchromosomal birth defects.
  271. The impact of a managed transition of care upon psychosocial characteristics and patient satisfaction in a cohort of adult survivors of childhood cancer
  272. Review: corticosteroids with intravenous immunoglobulin reduced the incidence of coronary artery aneurysm formation in patients with Kawasaki disease
  273. Faculty of 1000 evaluation for A new technique for fast and safe collection of urine in newborns.
  274. Developing a national ‘low risk’ febrile neutropenia framework for use in children and young people's cancer care
  275. Faculty of 1000 evaluation for Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds.
  276. Towards evidence based medicine for paediatricians
  277. Faculty of 1000 evaluation for Antibiotic use in children and the use of medicines by parents.
  278. Towards evidence based medicine for paediatricians
  279. A systematic review of models of care for the follow‐up of childhood cancer survivors
  280. Rationalizing the approach to children with fever in neutropenia
  281. Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile Neutropenia
  282. Fluoroquinolones in Children With Fever and Neutropenia
  283. Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: a systematic review
  284. Faculty of 1000 evaluation for Barriers to translating diagnostic research in febrile children to clinical practice: a systematic review.
  285. Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol)
  286. Are we sure about the evidence for zinc in prophylaxis of the common cold?
  287. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer
  288. Towards evidence based medicine for paediatricians
  289. Faculty of 1000 evaluation for Scald risk in social housing can be reduced through thermostatic control system without increasing Legionella risk: a cluster randomised trial.
  290. Towards evidence based medicine for paediatricians
  291. Systematic review and meta‐analysis of the value of clinical features to exclude radiographic pneumonia in febrile neutropenic episodes in children and young people
  292. Faculty Opinions recommendation of Oral acyclovir suppression and neurodevelopment after neonatal herpes.
  293. Faculty of 1000 evaluation for Systematic review of studies comparing combined treatment with paracetamol and ibuprofen, with either drug alone.
  294. Towards evidence based medicine for paediatricians
  295. Faculty of 1000 evaluation for Randomised trial of sidecar crib use on breastfeeding duration (NECOT).
  296. A Home-based Maintenance Therapy Program for Acute Lymphoblastic Leukemia—Practical and Safe?
  297. Urine catecholamines in paediatrics
  298. Towards evidence based medicine for paediatricians
  299. Faculty of 1000 evaluation for Mental health problems among children one-year after Sichuan earthquake in China: a follow-up study.
  300. Faculty of 1000 evaluation for The stability of the diagnosis of developmental disability between ages 2 and 8 in a geographic cohort of very preterm children born in 1997.
  301. Towards evidence based medicine for paediatricians
  302. A simple practical patient-reported clinic satisfaction measure for young adults
  303. Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people
  304. Faculty of 1000 evaluation for Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy.
  305. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood
  306. Supportive Care: Physical Consequences of Cancer and its Therapies
  307. Faculty of 1000 evaluation for Efficacy of sweet solutions for analgesia in infants between 1 and 12 months of age: a systematic review.
  308. ‘Cross hairs’ plots for diagnostic meta‐analysis
  309. Clinical decision rules: how to build them
  310. Clinical decision rules: how to use them
  311. Faculty of 1000 evaluation for Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
  312. Faculty of 1000 evaluation for Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis.
  313. Faculty of 1000 evaluation for Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies.
  314. Faculty Opinions recommendation of The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status.
  315. Challenges in the Management of Paediatric Febrile Neutropenia
  316. Faculty of 1000 evaluation for Influenza vaccination in children being treated with chemotherapy for cancer.
  317. Faculty of 1000 evaluation for Nebulized hypertonic saline solution for acute bronchiolitis in infants.
  318. F1000Prime recommendation of Evaluation of PICO as a knowledge representation for clinical questions.
  319. Faculty of 1000 evaluation for Does this child have acute otitis media?
  320. Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system
  321. Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group